Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overview: Initial antimicrobial therapy for microbial keratitis.

Literature DB >> 12928292

Overview: Initial antimicrobial therapy for microbial keratitis.

M Daniell¹.

Abstract

Entities: Disease

Mesh：

Substances：
Anti-Bacterial Agents

Year: 2003 PMID： 12928292 PMCID： PMC1771827 DOI： 10.1136/bjo.87.9.1172

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

× No keyword cloud information.

18 in total

1. Conjunctival necrosis after administration of topical fortified aminoglycosides.

Authors: C R Davison; S J Tuft; J K Dart
Journal: Am J Ophthalmol Date: 1991-06-15 Impact factor: 5.258

2. Strategies for the management of microbial keratitis.

Authors: B D Allan; J K Dart
Journal: Br J Ophthalmol Date: 1995-08 Impact factor: 4.638

3. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa.

Authors: N A Chaudhry; H W Flynn; T G Murray; H Tabandeh; M O Mello; D Miller
Journal: Am J Ophthalmol Date: 1999-10 Impact factor: 5.258

4. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.

Authors:
Journal: Ophthalmology Date: 1997-11 Impact factor: 12.079

5. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.

Authors: M H Goldstein; R P Kowalski; Y J Gordon
Journal: Ophthalmology Date: 1999-07 Impact factor: 12.079

6. Ciprofloxacin-resistant Pseudomonas keratitis.

Authors: P Garg; S Sharma; G N Rao
Journal: Ophthalmology Date: 1999-07 Impact factor: 12.079

7. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.

Authors: R A Hyndiuk; R A Eiferman; D R Caldwell; G O Rosenwasser; C I Santos; H R Katz; S S Badrinath; M K Reddy; J P Adenis; V Klauss
Journal: Ophthalmology Date: 1996-11 Impact factor: 12.079

8. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group.

Authors: K R Wilhelmus; R A Hyndiuk; D R Caldwell; R L Abshire; A T Folkens; L B Godio
Journal: Arch Ophthalmol Date: 1993-09

9. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.

Authors: T P O'Brien; M G Maguire; N E Fink; E Alfonso; P McDonnell
Journal: Arch Ophthalmol Date: 1995-10

10. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.

Authors: D Y Kunimoto; S Sharma; P Garg; G N Rao
Journal: Ophthalmology Date: 1999-01 Impact factor: 12.079

5 in total

1. Initial therapy for suppurative microbial keratitis in Iraq.

Authors: Faiz Al-Shakarchi
Journal: Br J Ophthalmol Date: 2007-06-27 Impact factor: 4.638

2. Correlation between human tear cytokine levels and cellular corneal changes in patients with bacterial keratitis by in vivo confocal microscopy.

Authors: Takefumi Yamaguchi; Bernardo M Calvacanti; Andrea Cruzat; Yureeda Qazi; Shizu Ishikawa; Akinori Osuka; James Lederer; Pedram Hamrah
Journal: Invest Ophthalmol Vis Sci Date: 2014-10-16 Impact factor: 4.799